ARCHIVES

New Center Plan Discussed By NAB, Directors Committees

This article is from The Cancer Letter archive.

Vol. 16 No. 18 | May 4, 1990

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007

Program Announcements For Tobacco Research

January 21, 1983

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

In Brief: Berlin Leaving Northwestern To Become Zubrod’s Deputy at Miami; Four Center Director Jobs Open

August 7, 1987